BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mwinyi J, Wenger C, Eloranta JJ, Kullak-Ublick GA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol 2010; 16(31): 3888-3896 [PMID: 20712049 DOI: 10.3748/wjg.v16.i31.3888]
URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3888.htm
Number Citing Articles
1
Mesut Savas, Elisabeth F.C. van Rossum. Encyclopedia of Endocrine Diseases2019; : 147 doi: 10.1016/B978-0-12-801238-3.65339-4
2
Qian-Qian Song, Wan-Ying Xie, Yong-Jun Tang, Jun Zhang, Jie Liu. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatmentPharmacogenomics 2017; 18(3): 293 doi: 10.2217/pgs-2016-0151
3
Sarah Tayler, Katarina Hazuchova, Anna Riddle, James W. Swann, Barbara Glanemann. Investigation of single‐nucleotide polymorphisms in the NR3C1a glucocorticoid receptor gene in Cocker Spaniels with primary immune thrombocytopeniaJournal of Veterinary Internal Medicine 2022; 36(4): 1281 doi: 10.1111/jvim.16468
4
MICHAŁ PANEK, TADEUSZ PIETRAS, ARTUR FABIJAN, MACIEJ MIŁANOWSKI, ŁUKASZ WIETESKA, PAWEŁ GÓRSKI, PIOTR KUNA, JANUSZ SZEMRAJ. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypesExperimental and Therapeutic Medicine 2013; 5(2): 572 doi: 10.3892/etm.2012.809
5
Seyede Mina Hejazian, Sepideh Zununi Vahed, Hakimeh Moghaddas Sani, Ziba Nariman-Saleh-Fam, Milad Bastami, Seyed Mahdi Hosseiniyan Khatibi, Mohammadreza Ardalan, Nasser Samadi. Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and viewsExpert Review of Clinical Pharmacology 2020; 13(2): 147 doi: 10.1080/17512433.2020.1702877
6
A. Costa, R. K. Sellon, M. Court, N. S. Burke, K. L. Mealey. Polymorphisms in the canine glucocorticoid receptor alpha gene (NR3C1α)Journal of Veterinary Pharmacology and Therapeutics 2016; 39(1): 16 doi: 10.1111/jvp.12241
7
Sara Rufini, Cinzia Ciccacci, Giuseppe Novelli, Paola Borgiani. Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's diseasePharmacogenomics 2017; 18(11): 1095 doi: 10.2217/pgs-2017-0068
8
Shannon D Whirledge, Christine M Jewell, Lisa M Barber, Xiaojiang Xu, Kevin S Katen, Stavros Garantziotis, John A Cidlowski. Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptorLaboratory Investigation 2017; 97(11): 1282 doi: 10.1038/labinvest.2017.76
9
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel diseaseExpert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1209 doi: 10.1080/17425255.2018.1551876
10
Jan W. Koper, Elisabeth F.C. van Rossum, Erica L.T. van den Akker. Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and diseaseSteroids 2014; 92: 62 doi: 10.1016/j.steroids.2014.07.015
11
Marcin Gabryel, Marzena Skrzypczak-Zielinska, Marcin A. Kucharski, Ryszard Slomski, Agnieszka Dobrowolska. The impact of genetic factors on response to glucocorticoids therapy in IBDScandinavian Journal of Gastroenterology 2016; 51(6): 654 doi: 10.3109/00365521.2015.1132336
12
Marianne Sidoroff, Kaija-Leena Kolho. Glucocorticoid sensitivity in inflammatory bowel diseaseAnnals of Medicine 2012; 44(6): 578 doi: 10.3109/07853890.2011.590521
13
Hong-Lin Chen, Li-Ren Li. Glucocorticoid Receptor Gene Polymorphisms and Glucocorticoid Resistance in Inflammatory Bowel Disease: A Meta-AnalysisDigestive Diseases and Sciences 2012; 57(12): 3065 doi: 10.1007/s10620-012-2293-2
14
Chentao Zou, Xinquan Zan, Zhenyu Jia, Lu Zheng, Yijie Gu, Fei Liu, Ye Han, Chunfang Xu, Airong Wu, Qiaoming Zhi. Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectivesClinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1479
15
Sophie E. Berends, Anne S. Strik, Mark Löwenberg, Geert R. D’Haens, Ron A. A. Mathôt. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative ColitisClinical Pharmacokinetics 2019; 58(1): 15 doi: 10.1007/s40262-018-0676-z
16
Aleksandra Szczepankiewicz, Anna Leszczyńska-Rodziewicz, Joanna Pawlak, Aleksandra Rajewska-Rager, Monika Dmitrzak-Weglarz, Monika Wilkosc, Maria Skibinska, Joanna Hauser. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorderJournal of Affective Disorders 2011; 134(1-3): 138 doi: 10.1016/j.jad.2011.06.020
17
Perpétua do Socorro Silva Costa, Thayne Woycinck Kowalski, Lucas Rosa Fraga, Mariléa Furtado Feira, Ana Paula Nazário, Luis MarceloAranha Camargo, Daniele Iop de Oliveira Caldoncelli, Maria Irismar da Silva Silveira, Mara Helena Hutz, Lavínia Schüler-Faccini, Fernanda Sales Luiz Vianna. NR3C1, ABCB1, TNF and CYP2C19 polymorphisms association with the response to the treatment of erythema nodosum leprosumPharmacogenomics 2019; 20(7): 503 doi: 10.2217/pgs-2018-0192
18
Cristina Botelho Barra, Thais Ramos Villela, Nedstâni de Freitas Soares, Enrico Antônio Colosimo, André Rolim Belisário, Ana Cristina Simões e Silva, Ivani Novato Silva, Jun Mori. Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasiaPLOS ONE 2022; 17(12): e0279298 doi: 10.1371/journal.pone.0279298